Pediatric Hexavalent Combination Vaccine Granted FDA Approval
December 31st 2018Officials with the US FDA have approved a vaccine for use in children younger than age 5 that is indicated for immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Vaxelisâ„¢).
CDC: Overdose Related Deaths Linked to Synthetic Opioids are Rising
December 28th 2018More than 702,000 Americans died from drug overdoses from 1999 to 2017–about 10% of them in 2017 alone, according to findings from an in-depth CDC analysis of the latest available drug overdose death data from the National Center for Health Statistics.
FDA Approves Calaspargase Pegol-mknl for Acute Lymphoblastic Leukemia in Young Patients
December 21st 2018The FDA has approved calaspargase pegol-mknl (Asparlas, Servier Pharmaceuticals) as a component of a multi-agent chemotherapeutic regimen for acute lymphoblastic leukemia (ALL) in patients aged 1 month to 21 years.
AHA: Benefits of Statins Typically Outweigh Risks
December 10th 2018Statins have demonstrated substantial benefits in reducing heart attacks and stroke risk caused by blood clots in at-risk patients, and their benefits for most people outweigh the risks, according to a statement this week from the American Heart Association.